Brave Warrior Advisors Portfolio in 2026: Top Holdings & Recent Changes
Welcome to the Value Sense Blog, your resource for insights on the stock market! At Value Sense, we focus on intrinsic value tools and offer stock ideas with undervalued companies. Dive into our research products and learn more about our unique approach at valuesense.io
Explore diverse stock ideas covering technology, healthcare, and commodities sectors. Our insights are crafted to help investors spot opportunities in undervalued growth stocks, enhancing potential returns. Visit us to see evaluations and in-depth market research.
Glenn Greenberg, founder of Brave Warrior Advisors, continues to demonstrate disciplined value investing through strategic portfolio rebalancing. His Q3 2025 portfolio reveals a $4.3 billion concentrated approach with deliberate moves across financial services, healthcare, and consumer-facing businesses. Recent actions—including a new position in Elevance Health and significant reductions in Ryanair and TD SYNNEX—signal a tactical shift toward healthcare exposure while trimming positions that may have reached valuation targets.
Portfolio Overview: Concentrated Value with Surgical Precision
Portfolio Highlights (Q3 2025): - Market Value: $4,307.8M - Top 10 Holdings: 76.8% - Portfolio Size: 33 -2 - Average Holding Period: 15 quarters - Turnover: 12.1%
Brave Warrior's portfolio demonstrates the hallmark of disciplined value investing: extreme concentration paired with measured activity. With just 33 positions managing $4.3 billion, Greenberg's portfolio maintains a 76.8% weighting in the top 10 holdings—a level of conviction that reflects deep fundamental analysis rather than diversification for safety's sake. The 12.1% turnover rate indicates thoughtful rebalancing rather than reactive trading, while the 15-quarter average holding period (nearly four years) underscores patience in allowing thesis development to play out.
The portfolio's recent evolution is particularly telling. With two positions eliminated this quarter, Greenberg is pruning the portfolio to focus capital where conviction runs deepest. This disciplined approach—maintaining core positions while making surgical adjustments—characterizes value investors who understand that great returns come from owning excellent businesses at reasonable prices, not from constant portfolio churn.
Top Holdings Analysis: Healthcare Ascendant, Cyclicals Trimmed
The portfolio's composition reveals a strategic pivot toward defensive healthcare while moderating exposure to cyclical sectors. Elevance Health emerges as the new flagship position at 13.8% $592.6M, representing a fresh buy that signals conviction in healthcare's structural advantages. This move elevates healthcare to a prominent role in the portfolio, reflecting confidence in the sector's resilience and valuation appeal.
TD SYNNEX remains the second-largest holding at 12.5% $536.3M, though Greenberg reduced this position by 13.09%—suggesting the technology distributor may have reached a valuation threshold or that capital is being redeployed to higher-conviction ideas. OneMain Holdings holds steady at 10.2% $440.1M with minimal changes, indicating continued confidence in the consumer finance business despite modest trimming of 0.96%.
The financial services theme continues with SLM Corporation receiving a meaningful 10.61% addition, now representing 7.5% of assets $322.7M. This student loan servicer addition suggests Greenberg sees value in the sector's improving fundamentals. AutoNation (6.2%, $265.6M) and Lennar (5.9%, $252.8M) round out the consumer-facing holdings, though both saw modest reductions.
The most dramatic move came in Ryanair, which experienced a 24.07% reduction to 5.7% $246.0M. This substantial trim of the European low-cost carrier suggests either valuation concerns or a reassessment of the airline sector's outlook. Meanwhile, MPLX received a 4.50% addition, now at 5.2% $223.2M, maintaining exposure to midstream energy infrastructure. Builders FirstSource (5.1%, $218.9M) and Fidelity National Financial (4.9%, $211.1M) complete the top 10, with the latter receiving a modest 0.06% addition.
What the Portfolio Reveals About Current Strategy
Greenberg's Q3 positioning reflects several strategic themes:
Healthcare as a defensive anchor — The new Elevance Health position and continued financial services exposure suggest a portfolio tilted toward sectors with predictable cash flows and structural tailwinds. Healthcare benefits from aging demographics and pricing power, making it an attractive value play for patient investors.
Selective trimming of cyclicals — The substantial Ryanair reduction and TD SYNNEX trim indicate Greenberg is taking profits or reassessing cyclical exposure. This suggests caution about near-term economic headwinds or recognition that valuations have normalized in these sectors.
Financial services conviction — With positions in OneMain Holdings, SLM Corporation, and Fidelity National Financial, the portfolio maintains meaningful exposure to financial intermediaries. The SLM addition particularly signals confidence in consumer lending fundamentals.
Disciplined capital allocation — The 12.1% turnover and elimination of two positions demonstrate that Greenberg is willing to exit ideas that no longer meet his criteria, rather than holding losers out of inertia. This discipline is essential to long-term outperformance.
Patience with core holdings — The 15-quarter average holding period and "no change" actions on several positions indicate Greenberg's willingness to let winning theses compound. This contrasts sharply with the market's obsession with quarterly performance.
Most investors waste time on the wrong metrics. We've spent 10,000+ hours perfecting our value investing engine to find what actually matters.
Want to see what we'll uncover next - before everyone else does?
Find Hidden Gems First!
Portfolio Concentration Analysis
| Position | Value | % of Portfolio | Recent Change |
|---|---|---|---|
| Elevance Health Inc. (ELV) | $592.6M | 13.8% | Buy |
| TD SYNNEX Corporation (SNX) | $536.3M | 12.5% | Reduce 13.09% |
| OneMain Holdings, Inc. (OMF) | $440.1M | 10.2% | Reduce 0.96% |
| SLM Corporation (SLM) | $322.7M | 7.5% | Add 10.61% |
| AutoNation, Inc. (AN) | $265.6M | 6.2% | Reduce 0.04% |
| Lennar Corporation (LEN) | $252.8M | 5.9% | Reduce 7.03% |
| Ryanair Holdings plc (RYAAY) | $246.0M | 5.7% | Reduce 24.07% |
| MPLX LP (MPLX) | $223.2M | 5.2% | Add 4.50% |
| Builders FirstSource, Inc. (BLDR) | $218.9M | 5.1% | Reduce 1.20% |
| Fidelity National Financial, Inc. (FNF) | $211.1M | 4.9% | Add 0.06% |
The concentration evident in this table—with the top 10 positions representing 76.8% of portfolio assets—reflects Greenberg's conviction-based approach. Rather than spreading capital thinly across dozens of mediocre ideas, Brave Warrior deploys capital where deep research has identified genuine value. This concentration amplifies returns when theses play out correctly, though it also requires exceptional stock-picking skill and discipline.
The mix of adds and reduces across the top 10 reveals active management within a concentrated framework. Greenberg isn't simply holding static positions; he's continuously reassessing valuations and fundamentals, adding to positions that have become more attractive and trimming those approaching fair value. This dynamic approach—combining patience with tactical flexibility—characterizes sophisticated value investors.
Investment Lessons from Glenn Greenberg's Approach
Brave Warrior's portfolio structure offers several actionable lessons for individual investors:
Concentration requires conviction, not just confidence — Holding 13.8% in a single position demands deep understanding of Elevance Health's competitive advantages, management quality, and intrinsic value. Greenberg's willingness to concentrate reflects years of research and pattern recognition, not casual stock picking.
Trim winners, don't chase them — The Ryanair reduction and TD SYNNEX trim demonstrate that Greenberg sells positions that have appreciated significantly. This discipline prevents the common investor mistake of holding winners too long, waiting for "just a bit more" upside.
Financial services offer value in uncertain times — With meaningful exposure to OneMain Holdings, SLM Corporation, and Fidelity National Financial, the portfolio bets on financial intermediaries' ability to generate returns through credit cycles. This reflects confidence in the sector's structural economics.
Patience compounds returns — The 15-quarter average holding period means Greenberg's positions have time to develop. This patience allows compounding of earnings growth and multiple expansion, rather than relying on short-term trading gains.
Turnover discipline prevents style drift — At 12.1%, Greenberg's turnover is low enough to maintain a coherent strategy while high enough to allow tactical adjustments. This balance prevents the portfolio from becoming stale while avoiding the costs and taxes of excessive trading.
Portfolio pruning improves focus — Eliminating two positions this quarter signals that Greenberg is willing to exit ideas that no longer meet his criteria. This pruning keeps the portfolio lean and focused on the highest-conviction ideas.
Looking Ahead: What Comes Next?
Brave Warrior's Q3 positioning sets up intriguingly for 2026. The healthcare tilt—anchored by Elevance Health—positions the portfolio to benefit from demographic tailwinds and potential healthcare sector rotation if growth stocks face headwinds. The financial services exposure, particularly in SLM Corporation, suggests confidence that consumer lending fundamentals remain sound despite economic uncertainty.
The substantial Ryanair reduction raises questions about Greenberg's near-term outlook for cyclical sectors. If this trim reflects caution about economic growth, the portfolio may be positioned defensively. Conversely, if it simply reflects valuation normalization, Greenberg may be waiting for better entry points in cyclicals.
With 33 positions and a 12.1% turnover rate, Greenberg has demonstrated capacity for new ideas while maintaining discipline. The elimination of two positions suggests the portfolio is being refined rather than expanded, indicating selective deployment of capital. This disciplined approach—waiting for truly compelling opportunities rather than deploying capital for its own sake—often characterizes the best long-term investors.
FAQ About Brave Warrior Advisors Portfolio
Q: What does the new Elevance Health position signal about Greenberg's outlook?
A: The new buy in Elevance Health at 13.8% of the portfolio signals strong conviction in healthcare's structural advantages and valuation appeal. This move elevates healthcare to a core portfolio theme, suggesting Greenberg sees compelling value in the sector's ability to generate consistent returns through economic cycles.
Q: Why did Greenberg reduce Ryanair so dramatically?
A: The 24.07% reduction in Ryanair from 5.7% suggests either that the position reached a valuation target or that Greenberg reassessed the airline sector's outlook. This trim may reflect caution about cyclical exposure or recognition that the low-cost carrier's valuation no longer offers compelling value.
Q: How does the 12.1% turnover rate compare to other value investors?
A: At 12.1%, Brave Warrior's turnover is moderate—low enough to maintain a coherent long-term strategy but high enough to allow tactical adjustments. This contrasts with both passive buy-and-hold approaches (near 0% turnover) and active traders (30%+ turnover), positioning Greenberg as a disciplined active manager.
Q: What does the portfolio's concentration tell us about Greenberg's confidence?
A: The 76.8% weighting in the top 10 positions reflects exceptional confidence in Greenberg's stock-picking ability. This concentration amplifies returns when theses play out but requires rigorous research and discipline to avoid catastrophic losses if a major position deteriorates.
Q: How can I track Brave Warrior's portfolio moves going forward?
A: You can monitor Brave Warrior's quarterly 13F filings and portfolio changes on ValueSense's Brave Warrior Advisors tracker. Remember that 13F filings carry a 45-day reporting lag, so disclosed positions may differ from Greenberg's real-time holdings. ValueSense provides timely analysis, visualizations, and historical tracking to help you understand portfolio evolution and identify emerging themes.
Explore More Investment Opportunities
For investors seeking undervalued companies with high fundamental quality, our analytics team provides curated stock lists:
📌 50 Undervalued Stocks (Best overall value plays for 2026)
📌 50 Undervalued Dividend Stocks (For income-focused investors)
📌 50 Undervalued Growth Stocks (High-growth potential with strong fundamentals)
🔍 Check out these stocks on the Value Sense platform for free!